Cost-Effectiveness of Prophylactic Radiation in Patients with Asymptomatic Bone Metastases.

This study found that prophylactic radiation may represent a cost-effective treatment option by reducing the risk of skeletal-related events among patients with asymptomatic bone metastases. Longer follow-up and additional research defining efficacy and optimal target populations who benefit most from prophylactic radiation will help confirm these findings.